
Publication|Articles|October 15, 2026
Pharmacy Practice in Focus: Oncology
- October 2026
- Volume 8
- Issue 7
Peptide Vaccines: The Next Frontier in Precision Cancer Treatment
Author(s)Rebekah R. Dyer, PharmD, BCPS
Fact checked by: Ron Panarotti
Peptide cancer vaccines target neoantigens to boost T cells, with promising melanoma and pancreatic trials hinting at a new era in immunotherapy.
Advertisement
Advertisement
Vaccination is a simple, safe, and effective process that teaches the immune system to generate protective responses against specific diseases through active immunization.1 It is estimated that vaccines have averted approximately 154 million deaths, with 146 million specifically in children younger than 5 years.2 Although the practice of immunizing remains a cornerstone of public health and disease prevention, vaccination focus is expanding to consider the same principle of active immunization for established diseases such as cancer.3
Related to this article

Peer Reviewed
Creating institution-specific, literacy-friendly chemotherapy education sheets resulted in patient education materials with higher readability scores than similar materials from common chemotherapy education sites.

How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.

At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.

Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.

AI tools in pharmacy education risk eroding critical thinking, lab competency, and patient safety if used as substitutes for foundational learning.

Rather than requiring a new trial, the FDA extended evidence from carcinoma in situ to high-grade papillary-only disease, a new approach for this setting.

Nationwide Danish data presented at EASD 2026 link a widening cancer gap in type 2 diabetes largely to obesity-related cancers.
Advertisement
Advertisement

